126 related articles for article (PubMed ID: 3337455)
1. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.
Tsukamura M
Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
Tsukamura M; Ichiyama S; Miyachi T
Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
[No Abstract] [Full Text] [Related]
3. Comparison of antituberculosis drug regimens for lung disease caused by Mycobacterium avium complex.
Tsukamura M; Ichiyama S
Chest; 1988 Apr; 93(4):821-3. PubMed ID: 3349841
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
Tsukamura M; Ichiyama S
Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933
[No Abstract] [Full Text] [Related]
6. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
7. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains.
Tsukamura M; Miyachi T
Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064
[TBL] [Abstract][Full Text] [Related]
8. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
[TBL] [Abstract][Full Text] [Related]
9. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
10. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy of Mycobacterium avium-intracellulare pulmonary disease.
Etzkorn ET; Aldarondo S; McAllister CK; Matthews J; Ognibene AJ
Am Rev Respir Dis; 1986 Sep; 134(3):442-5. PubMed ID: 3752699
[TBL] [Abstract][Full Text] [Related]
12. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
13. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Heifets L
Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
[TBL] [Abstract][Full Text] [Related]
14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
Tsukamura M
Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
[No Abstract] [Full Text] [Related]
16. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Crowle AJ; Elkins N; May MH
Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
[TBL] [Abstract][Full Text] [Related]
17. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.
Horsburgh CR; Mason UG; Heifets LB; Southwick K; Labrecque J; Iseman MD
Am Rev Respir Dis; 1987 Feb; 135(2):418-21. PubMed ID: 3813205
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance profile of human Mycobacterium avium complex strains from India.
Venugopal D; Kumar S; Isa M; Bose M
Indian J Med Microbiol; 2007 Apr; 25(2):115-20. PubMed ID: 17582180
[TBL] [Abstract][Full Text] [Related]
19. Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.
Heifets LB; Iseman MD; Lindholm-Levy PJ
Drugs Exp Clin Res; 1987; 13(9):529-38. PubMed ID: 3428133
[TBL] [Abstract][Full Text] [Related]
20. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
